Commentary: Cutaneous presentation of cardiac myxoma

Affiliations

¹ Department of Anesthesia & Critical Care, Anesthesia Perioperative Medicine Clinic, University of Chicago, Chicago, Ill.
² Department of Anesthesia & Critical Care, Cardiac Anesthesia, University of Chicago, Chicago, Ill.

Editorial

Rebecca M Gerlach et al. JTCVS Tech. 2020.

. 2020 Jan 10:1:72.

doi: 10.1016/j.xjtc.2020.01.011. eCollection 2020 Mar.

¹ Department of Anesthesia & Critical Care, Anesthesia Perioperative Medicine Clinic, University of Chicago, Chicago, Ill.
² Department of Anesthesia & Critical Care, Cardiac Anesthesia, University of Chicago, Chicago, Ill.

No abstract available

Figures

1. Smith M., Chaudhry M.A., Lozano P., Humphrey M.B. Cardiac myxoma induced paraneoplastic syndromes: a review of the literature. Eur J Intern Med. 2012;23:669–673. - PubMed
1. Ajiro Y., Nino H., Ueda T., Bonkohara Y. Granulocyte-colony stimulating factor– and interleukin-1β positive cardiac myxoma accompanying neutrophilic dermatosis. J Thorac Cardiovasc Surg Tech. 2020;1:69–71. - PMC - PubMed
1. Soeparwata R., Poeml P., Schmid C., Neuhof H., Scheld H.H. Interleukin-6 plasma levels and tumor size in cardiac myxoma. J Thorac Cardiovasc Surg. 1996;112:1675–1677. - PubMed
1. Marzano A.V., Ortega-Loayza A.G., Heath M., Morse D., Genovese G., Cugno M. Mechanisms of inflammation in neutrophil-mediated skin diseases. Front Immunol. 2019;10:1059. - PMC - PubMed